西洛他唑杂质B
|
|
|
- CAS号:
- 73963-62-9
- 英文名:
- 6-[4-(1-CYCLOHEXYL-1H-TETRAZOL-5-YL) BUTOXY]-2(1H)-QUINOLINONE
- 英文别名:
- OPC-13015;Cilostazol USP RC B;3,4-Dehydro Cilostazol;1H-tetrazol-5-yl)butoxy]-;cilostazol impurity B / RC-B;Cilostazol Related CoMpound B;ilostazol USP Related Compound B;Cilostazol Metabolite (OPC-13015);Cilostazol USP Related Compound B;2(1H)-Quinolinone, 6-[4-(1-cyclohexyl-
- 中文名:
- 西洛他唑杂质B
- 中文别名:
- 西洛他唑杂质B;西洛他唑杂质12;3,4-去氢西洛他唑;3,4-脱氢西洛他唑;西洛他唑相关化合物B;西洛他唑相关化合物B(USP);西洛他唑 USP 相关化合物 B;西洛他唑相关物质B USP标准品;CILOSTAZOL METABOLITE (OPC-13015);6-[4-(1-环己基-1H-四唑-5-基)丁氧基]-2(1H)-喹啉酮
- CBNumber:
- CB1220546
- 分子式:
- C20H25N5O2
- 分子量:
- 367.44
- MOL File:
- 73963-62-9.mol
|
|
|
西洛他唑杂质B化学性质
-
熔点:
-
179-180°C
-
|
-
储存条件:
-
-20°C Freezer
-
|
-
溶解度:
-
Chloroform (Slightly), DMSO (Slightly, Heated), Methanol (Slightly, Heated)
-
|
-
颜色:
-
White to Beige
-
|
-
BRN:
-
4273617
-
|
西洛他唑杂质B性质、用途与生产工艺
3,4-Dehydro Cilostazol (OPC-13015) 是西洛他唑 (Cilostazol; CLZ; HY-17464) 的活性代谢产物。3,4-Dehydro Cilostazol 可用于药代动力学研究。
3,4-Dehydro Cilostazol (OPC-13015; Oral; 1 mg/kg GLZ and 10 mg/kg CLZ) has a T
1/2
of 3.94 hours, a C
max
of 1.39 μM and an AUC
0-24
of 4.69 μg•h/ml. The plasma concentration time profiles of GLZ, CLZ & its active metabolite DCLZ are traceable up to 24 h, 12 h and 12 h respectively by oral administration at 1 mg/kg dose of GLZ and 10 mg/kg CLZ.
|
Animal Model:
|
Male Wistar rats weighing 200 g
|
|
Dosage:
|
1 mg/kg Glipizide (GLZ) and 10 mg/kg Cilostazol (CLZ) (Pharmacokinetic Analysis)
|
|
Administration:
|
Oral
|
|
Result:
|
Had a T
1/2
of 3.94 hours, a C
max
of 1.39 μM and an AUC
0-24
of 4.69 μg•h/ml.
|
西洛他唑杂质B
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/01/25 | HY-135910 | 西洛他唑杂质B
3,4-Dehydro Cilostazol | 73963-62-9 | 5mg | 1300元 |
| 2024/01/25 | HY-135910 | 西洛他唑杂质B
3,4-Dehydro Cilostazol | 73963-62-9 | 10mM * 1mLin DMSO | 1430元 |
73963-62-9, 西洛他唑杂质B 相关搜索:
- Various Metabolites and Impurities
- Metabolites & Impurities
- 抑制剂
- C20H25N5O2
- 西洛他唑杂质B
- 西洛他唑杂质12
- 西洛他唑 USP 相关化合物 B
- 6-[4-(1-环己基-1H-四唑-5-基)丁氧基]-2(1H)-喹啉酮
- 西洛他唑相关物质B USP标准品
- CILOSTAZOL METABOLITE (OPC-13015)
- 3,4-脱氢西洛他唑
- 西洛他唑相关化合物B
- 西洛他唑相关化合物B(USP)
- 3,4-去氢西洛他唑
- 73963-62-9
- cilostazol impurity B / RC-B
- 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)quinolin-2(1H)-one
- ilostazol USP Related Compound B
- Cilostazol Related Compound B (6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one) (1134175)
- 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]quinolin-2(1H)-on...
- 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-1H-quinolin-2-one
- Cilostazol USP RC B
- Cilostazol Metabolite (OPC-13015)
- Cilostazol USP Related Compound B
- 2(1H)-Quinolinone, 6-[4-(1-cyclohexyl-
- 1H-tetrazol-5-yl)butoxy]-
- Cilostazol Related CoMpound B
- 2(1H)-Quinolinone, 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-
- OPC-13015: 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl) butoxy]-2(1H)-Quinolinone
- Cilostazol Related Compound B (50 mg) (6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one)
- OPC-13015: 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)propoxy]-2(1H)-Quinolinone
- 3,4-Dehydro Cilostazol
- OPC-13015